IP Library Granted Patent US 11,878,115
Granted Patent B2
US 11,878,115 · App. 17/032,751 · Granted Jan 23, 2024

Internal cannula mounted nebulizer

Inventor: Scott A. Leonard (Bedford, NH)
Assignee: VAPOTHERM, INC.
A61M15/08A61M15/0085A61M16/0666A61M2205/50A61M2206/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,878,115
App. No.
17/032,751
Granted
Jan 23, 2024
Kind
B2
Abstract

Provided herein are devices, systems, and methods for providing respiratory therapy to a patient using a nasal cannula comprising a cannula body, first and second inlet tubes, and a nasal prong for the delivery of a flow of breathing gas to the patient. Configured with the cannula is a nebulizer having an aerosol generator positioned to emit aerosolized medicament along a longitudinal axis of the nasal prong. A flow director is configured to direct the flow of breathing gas into the nasal prong such that the breathing gas flows along the longitudinal axis, such that the flow of aerosolized medicament is contained within the flow of breathing gas as it moves along the longitudinal axis of the nasal prong for delivery to the patient.

Claims (25)

1. A system for providing respiratory therapy to a patient comprising:

a nasal cannula comprising a cannula body, first and second inlet tubes, and a nasal prong for the delivery of a flow of breathing gas to the patient, the flow of breathing gas supplied to the cannula body via the first and second inlet tubes,

the nasal prong having a longitudinal axis, an inlet in fluid communication with the cannula body, and an outlet for insertion into the nare of the patient;

a nebulizer adapted to receive a liquid medicament and having an aerosol generator positioned along and centered on the longitudinal axis at a point at which the flow of breathing gas has a theoretical zero flow rate, the aerosol generator operable to generate a flow of aerosolized medicament from the liquid medicament along the longitudinal axis; and

a flow director having a first portion and a second portion, the first portion coupled to the cannula body and adapted to receive the flow of breathing gas from the first and second inlet tubes and direct the flow of breathing gas into the nasal prong such that the breathing gas flows along the longitudinal axis, and

the second portion secured to the nebulizer and configured such that the flow of aerosolized medicament is contained within the flow of breathing gas as it moves along the longitudinal axis of the nasal prong for delivery to the patient,

wherein the flow of breathing gas is axisymmetric about the longitudinal axis of the nasal prong up to the point of theoretical zero flow rate, after which the flow is axially orientated with respect to the longitudinal axis of the nasal prong.

2. The system of claim 1 , wherein the breathing gas flows into the nasal prong along a path having a breathing gas axis that is symmetric along the longitudinal axis.

3. The system of claim 2 , wherein the flow director forms an annular gap between the inlet of the nasal prong and the nebulizer.

4. The system of claim 3 , wherein the flow director is configured such that the flow of breathing gas has a pressure drop in the nasal cannula that is largest across the annular gap.

5. The system of claim 4 , wherein the pressure drop in the flow of breathing gas across the annular gap is at least 30%.

6. The system of claim 3 , wherein the flow of breathing gas passes through the annular gap with a flow velocity that is constant at any point along the annular gap.

7. The system of claim 1 , wherein the flow director further comprises an anti-rotation element which prevents rotation of the flow of breathing gas within the cannula body as it is supplied to the cannula body via the first and second inlet tubes.

8. The system of claim 7 , wherein the anti-rotation element comprises a plurality of baffles symmetrically arranged about the flow director.

9. The system of claim 1 , wherein the nebulizer is removably attached to the flow director.

10. The system of claim 1 , wherein the flow director is coupled to the cannula body via an interference fit.

11. The system of claim 1 , wherein the aerosol generator comprises a vibrating mesh attached to a piezoelectric element.

12. The system of claim 11 , wherein the piezoelectric element is in electrical contact with a controller on a printed circuit board.

13. The system of claim 12 , further comprising wires that are in electrical contact with the printed circuit board for transmitting electrical signals from a signal generator to the vibrating mesh.

14. The system of claim 13 , further comprising a housing that is attached to the cannula body.

15. The system of claim 14 , wherein the housing is attached to the cannula body using a snap-fit connection.

16. The system of claim 15 , wherein the housing contains a reservoir filled with liquid medicament, the reservoir arranged such that the liquid medicament is in contact with an inner surface of the vibrating mesh.

17. The system of claim 16 , wherein the reservoir is in fluid communication with a liquid feed line comprising micro-bore tubing.

18. The system of claim 17 , wherein at least one of the liquid feed line or the wires is threaded through the first inlet tube or the second inlet tube of the nasal cannula.

19. The system of claim 1 , wherein the first and second inlet tubes are each coupled to a supply tube for fluidic communication with a source of breathing gas.

Assignments (5)
SECURITY INTEREST Recorded Apr 20, 2026
From: VAPOTHERM, INC.
To: PERCEPTIVE CAPITAL SOLUTIONS HOLDINGS LP
Reel/Frame 075477/0224 →
RELEASE OF SECURITY INTEREST Recorded Feb 23, 2022
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: VAPOTHERM, INC.
Reel/Frame 059218/0087 →
SECURITY INTEREST Recorded Feb 19, 2022
From: VAPOTHERM, INC.
To: SLR INVESTMENT CORP.
Reel/Frame 059203/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2021
From: LEONARD, SCOTT A.
To: VAPOTHERM, INC.
Reel/Frame 056791/0551 →
SECURITY INTEREST Recorded Oct 21, 2020
From: VAPOTHERM, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 054145/0212 →
Continuity (2)
Provisional Application 62906404 · Sep 26, 2019
Related Publication 20210093809A1 · Apr 1, 2021
Cited By (2)
US 12,702,771 US 12,702,781